Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00752531 · ClinicalTrials.gov registry record · NA

Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary Disorder

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
280
Enrollment target

NCT00752531: Completed NA study, sponsored by Johns Hopkins University.

NCT00752531 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 280 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00752531, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
280 participants
Enrollment target

Study Summary

All chronic obstructive pulmonary diseases (COPDs) block air flow to the lungs, and the two most common forms, emphysema and chronic bronchitis, are the most common causes of respiratory failure. Previous research shows that if COPD patients know more about their disease and how to manage it themselves, they will improve their quality of life and reduce their need for urgent care. However, traditional methods of teaching COPD patients about their disease and self-management skills are expensive and require intensive work. A new, less expensive way of reaching a large group of people with this information is needed to help patients stay healthier and happier with their treatment. This study will create a computer program that can help people learn about their disease and how to manage it themselves. This study will then determine whether the computer program, called Home Automated Telemanagement (HAT), helps patients with COPD in managing their disease and following their treatment plans.

Interventions

  • BEHAVIORAL Home Automated Telemanagement (HAT)

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2003-12
Est. Completion 2012-12
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00752531

The ClinicalTrials.gov registry entry for NCT00752531 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Home Automated Telemanagement (HAT) is the first listed.

NCT00752531 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00752531 about?

NCT00752531 is a clinical study titled "Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary Disorder". All chronic obstructive pulmonary diseases (COPDs) block air flow to the lungs, and the two most common forms, emphysema and chronic bronchitis, are the most common causes of respiratory failure. Previous research shows that if COPD patients know more about their disease and how to manage it themsel...

What is the current status of trial NCT00752531?

This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2003-12. Estimated completion is 2012-12.

What interventions are being tested in trial NCT00752531?

The interventions under investigation include: Home Automated Telemanagement (HAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00752531?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.